The US Food and Drug Administration recently published an alert regarding Boston Scientific’s Watchman product, a heart ...

The US Food and Drug Administration (FDA) has granted de novo authorisation to Artera’s ArteraAI Prostate software.

Vicarious Surgical has delayed the clinical timeline for its surgical robot, having previously stated it would initiate first ...

Reprieve Cardiovascular has closed an oversubscribed Series B financing round, raising $61m, for the trial of the Reprieve ...

The rise of agentic artificial intelligence (AI) is liable to have multiple use cases for healthcare in patient-facing areas ...

Patient demonstrations, ongoing clinical trials and heavy investment signal that BCIs could be commercialised by 2030.